直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Federal Circuit Affirms Principle of Party Presentation Allows the Parties, Not the Court, to Chart the Course of a Litigation

October 9, 2024

Authored and Edited by Emma N. Ng; Christina Ji-Hye Yang; Erik R. Puknys

In Astellas Pharma, Inc. v. Sandoz Inc., No. 23-2032 (Fed. Cir. Sept. 18, 2024), the Federal Circuit vacated the district court’s judgment and remanded the case.

Astellas’s ’780 patent relates to a sustained release formulation for the drug mirabegron. Following a bench trial, which was limited to infringement and validity under 35 U.S.C. § 112, the district court held sua sponte that the ’780 patent was invalid as directed to patent-ineligible subject matter under 35 U.S.C. § 101.

The Federal Circuit held the district court erred by disregarding the principle of party presentation and abused its discretion because patent eligibility was not raised below by Sandoz. The Federal Circuit stated that “[i]t is for the parties—not the court—to chart the course of litigation.” While Sandoz argued during oral argument that it pleaded an invalidity defense under § 101 in its answer, the Federal Circuit noted this argument was not raised on appeal and was thus forfeited.

The Federal Circuit declined to grant reassignment to a different judge on remand. The Federal Circuit was not convinced that the presiding judge could not resolve the outstanding issues impartially and fairly, particularly since the Federal Circuit clarified the “proper course for adjudication” on remand.

Tags

patentable subject matter, 35 U.S.C. § 101

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Global IP Enforcement, Litigation, and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Offices

Palo Alto, CA

Washington, DC

Contacts

Emma N. Ng
Associate
Washington, DC
+1 202 408 4149
Email
Christina Ji-Hye Yang
Partner
Washington, DC
+1 202 408 4465
Email
Erik R. Puknys
Partner
Palo Alto, CA
+1 650 849 6644
Email

Related Insights

Conference

IAM Live: Navigating the UPC 2026

November 3, 2026

Paris

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

2026 AIPLA Annual Meeting

October 29-31, 2026

Washington, DC

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Hybrid Conference

Intellectual Property Law Institute 2026 – California

October 19-20, 2026

San Francisco

Conference

31st Annual UMass Chan Research Retreat

October 14-15, 2026

Worcester

Hybrid Conference

Intellectual Property Law Institute 2026 – New York

September 28-29, 2026

New York

Conference

2026 IPO Annual Meeting

September 27-29, 2026

Toronto

Lecture

Resolving Patent Suits Without Settlement Payments

September 3, 2026

Virtual

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP